Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mann, J. R.
Right arrow Articles by Stine, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mann, J. R.
Right arrow Articles by Stine, C. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Am J Epidemiol 2003; 158:193.
Copyright © 2003 by Johns Hopkins Bloomberg School of Public Health

LETTERS TO THE EDITOR

RE: "INVITED COMMENTARY: CONDOM EFFECTIVENESS—WILL PROSTATE-SPECIFIC ANTIGEN SHED NEW LIGHT ON THIS PERPLEXING PROBLEM?"

Joshua R. Mann1 and Curtis S. Stine2

1 Department of Family and Preventive Medicine, University of South Carolina School of Medicine, Columbia, SC 29203.
2 Florida State University College of Medicine, Tallahassee, FL 32306.

The first 10% of the full text of this article appears below.

Recent articles in the American Journal of Epidemiology described the use of postcoital vaginal prostate-specific antigen levels to evaluate the effectiveness of the female condom as a semen barrier (1, 2). The findings of these studies indicated that women who were trained in the use of the female condom were . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?